Newsroom

LONDON--(BUSINESS WIRE)--  15-December-2025 Issue: Co-operative Bank plc CB 2025-1 XS3049417317 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 22-September-2025 Date To: 22-December-2025 Record Date: 19-December-2025 Value Date: 22-December-2025 Benchmark Rate: 3.9885% Margin: 0.57% Total Rate: 4.5585% Floor: 0% Number of Days: 91 Day Count: Actual / 365 (Fixed) Interest Frequency: Quarterly Denominatio...

LONDRA--(BUSINESS WIRE)--Nexo, importante piattaforma di asset digitali, ha siglato uno storico accordo di collaborazione pluriennale con Tennis Australia ed è diventato Official Crypto Partner degli Australian Open e della Summer of Tennis, che include eventi come la United Cup, l'Adelaide International, il Brisbane International e l'Hobart International. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte...

LONDON--(BUSINESS WIRE)--  15-December-2025 Issue: Co-operative Bank plc CB XS2838925902 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 22-September-2025 Date To: 22-December-2025 Record Date: 19-December-2025 Value Date: 22-December-2025 Benchmark Rate: 3.9885% Margin: 0.53% Total Rate: 4.5185% Floor: 0% Number of Days: 91 Day Count: Actual / 365 (Fixed) Interest Frequency: Quarterly Denomination: GBP...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive topline results from the Phase 3 KEYNOTE-B15 trial (also known as EV-304) in patients with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin-based chemotherapy. The trial showed KEYTRUDA® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv), given as neoadjuvant and adjuvant treatment (before and after surgery), demonstrated a statistically signific...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 16.12.2025 FEUD IE00BF2FL590  366,243.00 EUR  18,257,327.51   49.850  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 16.12.2025 SDVI.LN IE000YVOQ2A3 40,361.00 USD 1,068,875.16 26.483  ...

LONDON--(BUSINESS WIRE)--  15-December-2025 Issue: Clydesdale Bank plc CB Series 10 XS3095269539 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 22-September-2025 Date To: 22-December-2025 Record Date: 19-December-2025 Value Date: 22-December-2025 Benchmark Rate: 3.98849% Margin: 0.8% Total Rate: 4.78849% Floor: 0% Number of Days: 91 Day Count: Actual / 365 (Fixed) Interest Frequency: Quarterly Denominat...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 16.12.2025 FEUZ IE00B8X9NY41 1,103,799.00 EUR  62,017,036.89   56.185  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 16.12.2025 SDVY.LN IE0001R850E1 10,779,007.00 USD 250,651,682.81 23.254  ...

LONDON--(BUSINESS WIRE)--  15-December-2025 Issue: Clydesdale Bank plc CB SERIES 8 XS2692456200 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 22-September-2025 Date To: 22-December-2025 Record Date: 19-December-2025 Value Date: 22-December-2025 Benchmark Rate: 3.98849% Margin: 0.6% Total Rate: 4.58849% Number of Days: 91 Day Count: Actual / 365 (Fixed) Interest Frequency: Quarterly Denomination: GBP 1,...